BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17822790)

  • 1. HOIL-1 is not required for iron-mediated IRP2 degradation in HEK293 cells.
    Zumbrennen KB; Hanson ES; Leibold EA
    Biochim Biophys Acta; 2008 Feb; 1783(2):246-52. PubMed ID: 17822790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2.
    Yamanaka K; Ishikawa H; Megumi Y; Tokunaga F; Kanie M; Rouault TA; Morishima I; Minato N; Ishimori K; Iwai K
    Nat Cell Biol; 2003 Apr; 5(4):336-40. PubMed ID: 12629548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox control of iron regulatory protein 2 stability.
    Hausmann A; Lee J; Pantopoulos K
    FEBS Lett; 2011 Feb; 585(4):687-92. PubMed ID: 21281640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
    Bayle J; Lopez S; Iwaï K; Dubreuil P; De Sepulveda P
    FEBS Lett; 2006 May; 580(11):2609-14. PubMed ID: 16643902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis.
    Salahudeen AA; Thompson JW; Ruiz JC; Ma HW; Kinch LN; Li Q; Grishin NV; Bruick RK
    Science; 2009 Oct; 326(5953):722-6. PubMed ID: 19762597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, expression, and assay of an oxidation-specific ubiquitin ligase, HOIL-1.
    Iwai K; Ishikawa H; Kirisako T
    Methods Enzymol; 2005; 398():256-71. PubMed ID: 16275334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL.
    Wang J; Pantopoulos K
    Biochim Biophys Acta; 2005 Mar; 1743(1-2):79-85. PubMed ID: 15777842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2.
    Ishikawa H; Kato M; Hori H; Ishimori K; Kirisako T; Tokunaga F; Iwai K
    Mol Cell; 2005 Jul; 19(2):171-81. PubMed ID: 16039587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human iron regulatory protein 2 is easily cleaved in its specific domain: consequences for the haem binding properties of the protein.
    Dycke C; Bougault C; Gaillard J; Andrieu JP; Pantopoulos K; Moulis JM
    Biochem J; 2007 Dec; 408(3):429-39. PubMed ID: 17760563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron regulatory protein 2 turnover through a nonproteasomal pathway.
    Chang AH; Jeong J; Levine RL
    J Biol Chem; 2011 Jul; 286(27):23698-707. PubMed ID: 21558272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2.
    Bourdon E; Kang DK; Ghosh MC; Drake SK; Wey J; Levine RL; Rouault TA
    Blood Cells Mol Dis; 2003; 31(2):247-55. PubMed ID: 12972033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen and iron regulation of iron regulatory protein 2.
    Hanson ES; Rawlins ML; Leibold EA
    J Biol Chem; 2003 Oct; 278(41):40337-42. PubMed ID: 12888568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity.
    Wang J; Chen G; Muckenthaler M; Galy B; Hentze MW; Pantopoulos K
    Mol Cell Biol; 2004 Feb; 24(3):954-65. PubMed ID: 14729944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of iron homeostasis by an iron-regulated ubiquitin ligase.
    Vashisht AA; Zumbrennen KB; Huang X; Powers DN; Durazo A; Sun D; Bhaskaran N; Persson A; Uhlen M; Sangfelt O; Spruck C; Leibold EA; Wohlschlegel JA
    Science; 2009 Oct; 326(5953):718-21. PubMed ID: 19762596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178.
    Wang J; Fillebeen C; Chen G; Andriopoulos B; Pantopoulos K
    Mol Cell Biol; 2006 Mar; 26(5):1948-54. PubMed ID: 16479012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and biochemical characterization of iron regulatory proteins 1 and 2 in Saccharomyces cerevisiae.
    Phillips JD; Guo B; Yu Y; Brown FM; Leibold EA
    Biochemistry; 1996 Dec; 35(49):15704-14. PubMed ID: 8961933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for lysosomes in the turnover of human iron regulatory protein 2.
    Dycke C; Charbonnier P; Pantopoulos K; Moulis JM
    Int J Biochem Cell Biol; 2008; 40(12):2826-32. PubMed ID: 18582596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome.
    Guo B; Phillips JD; Yu Y; Leibold EA
    J Biol Chem; 1995 Sep; 270(37):21645-51. PubMed ID: 7665579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron-dependent degradation of IRP2 requires its C-terminal region and IRP structural integrity.
    Wang J; Chen G; Lee J; Pantopoulos K
    BMC Mol Biol; 2008 Jan; 9():15. PubMed ID: 18226225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXL5 Regulates IRP2 Stability in Iron Homeostasis via an Oxygen-Responsive [2Fe2S] Cluster.
    Wang H; Shi H; Rajan M; Canarie ER; Hong S; Simoneschi D; Pagano M; Bush MF; Stoll S; Leibold EA; Zheng N
    Mol Cell; 2020 Apr; 78(1):31-41.e5. PubMed ID: 32126207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.